Literature DB >> 19710555

Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nails.

Knud Kragballe.   

Abstract

Psoriasis located on the scalp, face, skin folds, palms/soles and nails may require special consideration due to physical disability and discomfort, and because the treatment efficacy and safety may be different. There are many therapeutic approaches for psoriasis in difficult to treat locations. Only a few of the therapies have been evaluated for efficacy and safety in well-designed and well-controlled clinical studies. Furthermore, comparative studies are often lacking. This chapter describes management of psoriasis located on the scalp, face, skin folds, palm/soles and nails, with special focus on treatment with topical agents. Copyright (c) 038\ S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19710555     DOI: 10.1159/000232309

Source DB:  PubMed          Journal:  Curr Probl Dermatol        ISSN: 1421-5721


  7 in total

1.  Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas.

Authors:  Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

Review 2.  Secukinumab in the Treatment of Palmoplantar, Nail, Scalp, and Pustular Psoriasis.

Authors:  April W Armstrong; Ron Vender; Leon Kircik
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

3.  Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey.

Authors:  Arthur Kavanaugh; Philip Helliwell; Christopher T Ritchlin
Journal:  Rheumatol Ther       Date:  2016-02-29

4.  An Open-label, Observational Study Evaluating Desoximetasone Topical Spray 0.25% in Patients with Scalp Psoriasis.

Authors:  Jerry Bagel; Elise Nelson
Journal:  J Clin Aesthet Dermatol       Date:  2018-05-01

5.  Mechanisms of action of topical corticosteroids in psoriasis.

Authors:  Luís Uva; Diana Miguel; Catarina Pinheiro; Joana Antunes; Diogo Cruz; João Ferreira; Paulo Filipe
Journal:  Int J Endocrinol       Date:  2012-11-05       Impact factor: 3.257

Review 6.  Challenging regional psoriasis and ustekinumab biotherapy: impact of the patterns of disease.

Authors:  Trinh Hermanns-Lê; Enzo Berardesca; Gérald E Piérard; Marianne Lesuisse; Claudine Piérard-Franchimont
Journal:  J Biomed Biotechnol       Date:  2012-08-13

7.  Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.

Authors:  Leon Kircik; Joseph Fowler; Jonathan Weiss; Xiangyi Meng; Adriana Guana; Judit Nyirady
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.